Retinoblastoma — Trials

Retinoblastoma — Trials · CancerIndex

Clinical trials

Registered studies

110 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 15
Recruiting: 8
Ph III recruiting: 3
Growth YoY: —
Industry share: 7%
Top sponsor: Institut Curie
Termination share: —

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (16)

clinicaltrialsPublishedShowing 1–11 of 11 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT00445965	Iodine I 131 Monoclonal Antibody 3F8 in Treating Patients With Central Nervous System Cancer or Leptomeningeal Cancer	completed	Phase 2	78	Memorial Sloan Kettering Cancer CenterOTHER	1	Apr 4, 2024	clinicaltrials
NCT00179920	Chemotherapy Treatment for Children With Intraocular Germ-Line Retinoblastoma	completed	Phase 2	30	Ann & Robert H Lurie Children's Hospital of ChicagoOTHER	1	Aug 5, 2020